Evidence map›Paper›PMID 31392246›Full record

ArticleMovement disorders clinical practice2019

An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

Jennifer L Whitwell, Chase A Stevens, Joseph R Duffy, Heather M Clark, Mary M Machulda, Edythe A Strand, Peter R Martin, Rene L Utianski, Hugo Botha, Anthony J Spychalla and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Movement disorders clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. An Update on Apraxia of Speech.Current neurology and neuroscience reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Jennifer L WhitwellDepartment of Radiology Mayo Clinic Rochester Minnesota.
Chase A StevensDepartment of Neurology Mayo Clinic Rochester Minnesota.
Joseph R DuffyDepartment of Neurology Mayo Clinic Rochester Minnesota.
Heather M ClarkDepartment of Neurology Mayo Clinic Rochester Minnesota.
Mary M MachuldaDepartment of Psychology and Psychiatry Mayo Clinic Rochester Minnesota.
Edythe A StrandDepartment of Neurology Mayo Clinic Rochester Minnesota.
Peter R MartinDepartment of Health Science Research Mayo Clinic Rochester Minnesota.
Rene L UtianskiDepartment of Neurology Mayo Clinic Rochester Minnesota.
Hugo BothaDepartment of Neurology Mayo Clinic Rochester Minnesota.
Anthony J SpychallaDepartment of Radiology Mayo Clinic Rochester Minnesota.
Matthew L SenjemDepartment of Radiology Mayo Clinic Rochester Minnesota.
Christopher G SchwarzDepartment of Radiology Mayo Clinic Rochester Minnesota.
Clifford R JackDepartment of Radiology Mayo Clinic Rochester Minnesota.
Farwa AliDepartment of Neurology Mayo Clinic Rochester Minnesota.
Anhar HassanDepartment of Neurology Mayo Clinic Rochester Minnesota.
Keith A JosephsDepartment of Neurology Mayo Clinic Rochester Minnesota.
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6M
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromesR37NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Jennifer Louise Whitwell · 2026 to 2026
$3.7M
PIB PET Scanning in Speech and Language Based DementiasR01DC010367 · NIDCD · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2014
$1.7M
NIDCD NIH HHS R01 DC010367NIDCD NIH HHS R01 DC012519NINDS NIH HHS R01 NS089757NINDS NIH HHS R37 NS089757
6 · The paper itself

Abstract

backgroundThe Movement Disorder Society clinical criteria for progressive supranuclear palsy (PSP) provide a framework for assessing the presence/severity of clinical symptoms and define a speech/language variant of PSP.

objectivesTo evaluate the clinical criteria in a cohort of speech/language patients with longitudinal follow-up.

methodsA total of 52 patients presenting with progressive apraxia of speech and/or agrammatic aphasia were followed longitudinally for up to 6 visits with clinical assessments and magnetic resonance imaging. We assessed oculomotor, postural instability, and akinesia diagnostic levels and determined whether patients met criteria for possible PSP-speech/language or probable PSP at each visit. Kaplan-Meier curves assessed time-to-event probabilities according to age. Statistical parametric mapping and midbrain volume were assessed according to disease progression.

resultsFew PSP symptoms were observed early in the disease, with oculomotor abnormalities and falls first observed 2 years after onset. Falls were more common than vertical supranuclear gaze palsy. Bradykinesia and rigidity commonly developed but axial was rarely greater than appendicular rigidity. During follow-up, 54% met criteria for possible PSP-speech/language, 38% for probable PSP-Richardson's syndrome, and 38% for probable PSP-parkinsonism, most commonly 6 to 6.9 years after onset. The probability of developing PSP was greater when onset was at an age older than 70 years. Patients who progressed to probable PSP had more parkinsonism and oculomotor impairment at baseline and greater midbrain atrophy when compared with those who did not develop probable PSP.

conclusionsSymptoms typical of PSP commonly develop in patients presenting with a progressive speech/language disorder. Older age appears to be an important prognostic factor in these patients.

Indexed as

agrammatismaphasiaapraxia of speechmidbrainPSP

Identifiers

PMID31392246
PMCPMC6660227
OpenAlexW2947762664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.